Our long-term objective is to commercialize a fast, simple, flexible, and economical system for affinity-tag protein purification and tag removal. This technology was developed as a result of NIH-funded studies on the folding, stability and enzymology of the Bacillus protease subtilisin. The transformative purification technology combines three components: 1) a regulated, highly-specific protease (Psub) that is constitutively inactive; 2) a small molecule (imidazole) that activates the Psub; 3) a high-affinity inhibitor (Pro). Immobilized Psub (in the off-state) can capture a Pro-fusion protein from a cellular extract, allowing contaminants to be washed away. Subsequent addition of imidazole to the immobilized complex releases pure, tag-free target protein and leaves the Pro-tag tightly bound to Psub. Recombinant proteins are frequently fused with other proteins or peptides to facilitate expression and purification. The tags enable target protein binding in affinity purification, but ultimately must be processed by a site-specific protease. Tag removal, however, is frequently expensive, inefficient, and sometimes problematic. The technical innovation of our system is the integration of seamless tag removal into the purification process. This provides simplicity, efficiency, and robustness that is not available in any other system. Improved understanding of protein engineering principles has resulted in highly-efficient Psubs and Pro affinity tags. The experimental plan has two goals. The first is to generate economical materials for purification of standard proteins without tags. The second goal more ambitious goal is to develop methods for purifying high-value proteins that are either difficult or impossible with current methods.
The Specific Aims are: 1) Evaluation of site-specific immobilization methods for Psub; 2) Cloning of challenging, high-value target proteins; 3) Expression-extraction-purification of high-value target proteins; 4) Optimization of the purification of challenging proteins; 5) Testing physical and biological properties of purified proteins. Better purification technology should advance in all areas of biology but have a particular impact on the production of growth factors needed for the growth, survival, and differentiation of therapeutic cells.

Public Health Relevance

Challenges in protein purification limit progress in biology and medicine. The purification technology being developed in this project should help advance in all areas of biology but have a particular impact on the production of growth factors needed for the growth, survival, and differentiation of therapeutic cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44GM126676-02
Application #
9776895
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Bond, Michelle Rueffer
Project Start
2019-07-01
Project End
2021-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
2
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Potomac Affinity Proteins, LLC
Department
Type
DUNS #
193771347
City
North Potomac
State
MD
Country
United States
Zip Code
20878